Nationwide survey of neurologic manifestations of acquired immunodeficiency syndrome in Japan [see comments] NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Nationwide survey of neurologic manifestations of acquired immunodeficiency syndrome in Japan [see comments]

Intern Med. 1997 Mar;36(3):175-8. Unique Identifier : AIDSLINE MED/97289085
Nakagawa M; Maruyama Y; Sugita H; Osame M; Third Department of Internal Medicine, Kagoshima University School of; Medicine.


Abstract: To study the epidemiology of the neurologic manifestations of human immunodeficiency virus (HIV)-1 infection in Japan, we conducted two nationwide surveys. Of 1854 HIV-1 carriers, 578 had acquired immunodeficiency syndrome (AIDS) and 166 (28.7% of AIDS patients) had neurologic manifestations including HIV dementia 11.8%), myelopathy (3.6%) and peripheral neuropathy (2.6%). The incidence of neurologic manifestations in patients with HIV-1 infection through blood products was about 60% of that in patients with HIV-1 infection through sex or unknown routes. This nationwide survey showed that the incidence of neurologic manifestations in AIDS patients in Japan was consistent with that in other countries.
Keywords: *Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY *AIDS Dementia Complex/EPIDEMIOLOGY *AIDS-Related Opportunistic Infections/EPIDEMIOLOGY *HIV Infections/EPIDEMIOLOGY *HIV-1 *Nervous System Diseases/EPIDEMIOLOGYKWDacquiredimmunodeficiencysyndrome/epidemiologyKWDaidsdementiacomplex/epidemiologyKWDaids-relatedopportunisticinfections/epidemiologyKWDhivinfections/epidemiologyKWDhiv-1KWDnervoussystemdiseases/epidemiology
Comment in: Intern Med 1997 Mar;36(3):160-1
970930
M9791383

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .